Journal
BRITISH JOURNAL OF CANCER
Volume 96, Issue 8, Pages 1178-1182Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6603699
Keywords
WHO classification; urinary 5-hydroxyindoleacetic acid; liver function tests; neuroendocrine carcinomas; gastroenteropancreatic tract
Categories
Ask authors/readers for more resources
The World Health Organisation (WHO) classification (2000) is widely used to classify neuroendocrine carcinomas (NECs), yet its prognostic value needs to be confirmed. In this study, patients with metastatic NECs (n=119) were classified according to WHO guidelines into well differentiated and poorly differentiated (WDNECs and PDNECs). Histological differentiation based on WHO criteria had the highest impact on overall survival (OS) (PDNECs : WDNECs hazard ratio (HR)=4.02, P= 0.02); however, PDNECs represented only a small percentage of patients (8%). In a WDNEC-restricted analysis, abnormal liver function tests (LFTs) and elevated urinary 5-hydroxyindoleacetic acid (u5HIAA) were independent prognostic factors for survival (HR= 2.65, P= 0.006 and HR= 2.51, P= 0.003, respectively) and were used to create a WDNEC-specific prognostic model (low risk both normal, intermediate risk =one of them abnormal, high risk = both abnormal). Low-risk WDNECs had the most favourable prognosis (median OS, mOS 8.1 years), which was significantly better compared to both intermediate- risk and high-risk WDNECs (mOS 3.2 and 1.4 years, with P = 0.01 and P < 0.001, respectively). High-risk WDNECs displayed the shortest OS (1.3 years), which was similar to that of PDNECs (P=0.572). This analysis supports the prognostic value of WHO classification for metastatic NECs arising from the gastroenteropancreatic tract; however, risk stratification using readily available u5HIAA and LFTs may be necessary for the heterogeneous group of WDNECs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available